IPC Forges Strategic Alliances with PMBI and NIPER Hajipur to Redefine India’s Drug Safety and Pharma Research Landscape
Under the visionary leadership of Hon’ble Prime Minister Shri Narendra Modi, India continues to fortify its commitment to accessible, high-quality healthcare. In a landmark...
AbbVie Moves Toward “Fast-Acting” Botox Alternative: FDA Requests Final Manufacturing Details for 24-Hour Frown Line Treatment
AbbVie is set to rewrite the timeline of aesthetic medicine, as it received the receipt of a Complete Response Letter (CRL) from the...
Johnson & Johnson to Acquire Atraverse Medical to Expand Cardiac Care Portfolio
Johnson & Johnson has entered into a definitive agreement to acquire Atraverse Medical, a medical device innovator focused on left-heart access technologies. The move...
New Hope for MOGAD Patients: ENSPRYNG Demonstrates Unparalleled 68% Reduction in Disabling Relapses
The Phase III METEOROID study, revealed ENSPRYNG (satralizumab) showing reduction in the risk of relapses by 68% in patients compared to placebo,according to...
India Expands COVID-19 Vaccine Portfolio with New Approvals Including Omicron JN.1 Variant Shot
India’s COVID-19 vaccination landscape continues to evolve, with the Central Drugs Standard Control Organization (CDSCO) releasing an updated list of approved vaccines as of...
Merck Launches Industry-First Bio-Based Solvent Portfolio for (HPLC)
In a significant step toward greener laboratory practices, Merck Group has launched the industry’s first bio-based solvent portfolio designed specifically for high-performance liquid chromatography...
